Personalized therapy in cancer marks a groundbreaking shift from one-size-fits-all treatments to tailored approaches based on an individual's genetic makeup, tumor characteristics, and other factors. This approach leverages cutting-edge technologies like next-generation sequencing to analyze a patient's tumor at the molecular level, identifying specific mutations and biomarkers that drive cancer growth. Armed with this information, oncologists can prescribe targeted therapies that precisely address the unique vulnerabilities of each tumor, maximizing effectiveness while minimizing side effects. Additionally, personalized therapy extends beyond genomic profiling, encompassing immunotherapies that harness the body's immune system to fight cancer. By customizing treatment strategies to the intricacies of each patient's disease, personalized therapy represents a paradigm shift in cancer care, offering new hope for improved outcomes and quality of life.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States